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A Pharmacist's Role in Educating on the Health Risks of Smoking
During Pregnancy and Helping Patients with Smoking Cessation
Alexandra Herman, Cassandra Hacker, Emily Wells, Brian Heilbronner, Brittany L. Long, PharmD, TTS

Abstract
While many people know smoking causes cancer, heart disease and other major health problems, smoking during pregnancy causes additional fetal health complications including
birth defects, premature birth and infant death. Cigarettes
contain carbon monoxide and nicotine, both of which can
cause a decrease in oxygen delivery to the fetus' developing
tissues causing organs like the brain, lungs, kidneys and ears
not to develop properly. If children are exposed to these toxins through secondhand smoke after birth, they are more
likely to experience severe health problems such as ear infections, cataracts, lung cancer and heart disease. It is also
;known that nicotine is found in high concentrations in breast
milk which allows it to be transferred to infants as they
breastfeed. Approximately 15 to 20 percent of pregnant
women smoke tobacco during pregnancy despite the strong
:public-health campaign over the last few decades. Because of
ithe risks and potential negative pregnancy outcomes, pharmacists have the duty to assess the patient's willingness to
quit smoking (during and after pregnancy) and, if receptive,
offer counseling and create a plan for cessation. Nonpharmacologic treatment is the best option for smoking cessation for
;women who are pregnant as it does not expose the fetus to
1any additional medications. The "S R's" are often used to in:fluence any patient, including pregnant women, to consider
:quitting smoking and to provide them with the right direc;tion to successfully quit. Nonpharmacologic options are the
most important for pregnant patients as pharmacologic
treatments have not been studied sufficiently to determine
·safety for the fetus.
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Introduction
The contribution of the pharmacist is key in facilitating
smoking cessation interventions in the community setting.
Conveniently located in a retail setting, pharmacists are easily accessible to patients who seek counseling and follow-up
consultation during smoking cessation. Pharmacists have a
unique opportunity to counsel patients who are pregnant or
are considering becoming pregnant on the risks of smoking
during pregnancy as well as various treatment options for
smoking cessation. Smoking during pregnancy can cause various health problems and risks for both the mother and the
fetus including gestational bleeding, placental abruption,
placenta previa miscarriage and preterm birth.1,2 Additionally, tobacco smoke contains many chemicals that are
potentially toxic to fetal development. The most toxic include
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nicotine and carbon monoxide. Nonpharmacologic treatment
using the "5 A's" counseling technique is considered first-line
in order to prevent pregnancy complications and potential
birth defects.3
Health Risks of Smoking During Pregnancy
Numerous health risks of smoking during pregnancy exist.
Many are linked to nicotine and carbon monoxide.1 Pharmacists can educate patients on the specific health risks linked
to these chemicals. Specifically, nicotine has been shown to
cross the placenta and enter fetal circulation in both active
and passive smoking mothers resulting in an accumulation of
nicotine in the fetal compartments as early as seven weeks
gestation. The concentrations of nicotine in fetuses are
known to be higher with longer lasting effects than the
nicotine concentrations in the mothers. Evidence has shown
nicotine concentrations are 15 percent higher in fetal circulation compared to the mother's, while the amniotic fluid contains nicotine concentrations that are 88 percent higher than
those in the mother's plasma. These elevated concentrations
of nicotine can cause vasoconstriction of the uteroplacental
vasculature causing a decrease in the nutrients and oxygen
reaching the fetus.2 Nicotine also causes alterations in cellular growth in the peripheral and central nervous systems of
the fetus. Additionally, nicotine has been shown to suppress
appetite which results in less maternal food intake and potential nutritional deprivation of the fetus. Ultimately, this
causes a reduction in the energy supplied to the fetus which
may deter its growth and development.
Similarly, carbon monoxide has been shown to cross the placenta and bind to the hemoglobin in fetal circulation, displacing oxygen, which limits the delivery of oxygen to the tissues
and organs of the fetus resulting in hypoxic ischemiaP The
growth of the fetus during pregnancy depends on the oxygen
and nutrition supply to help the tissues to continue to develop. Normally when fetal oxygen levels are low, a protective
mechanism helps keep the brain supplied with oxygen. The
chemicals from the cigarette can cause this protection mechanism to work incorrectly, reducing the exposure of the brain
to oxygen, thus negatively impacting its growth and development. Specifically, the proposed mechanism is that nicotine
increases the apoptosis of various structures in the brain
including progenitor cells and postmitotic neurons.Considering the health concerns of carbon monoxide on fetal growth
and development, research suggests that maternal smoking
cessation early in pregnancy may support normal fetal head
and brain and the prevention of volumetric changes associated with the brain including thinning of the frontal, parietal
and temporal lobe which may take until adolescence to be
manifested.1 Changes and abnormalities in brain structure
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can cause long-term effects on behavior including an increased risk of Attention Deficient Hyperactivity Disorder
(ADHD).U The fetuses of smoking mothers have an additionally increased risk of being born at a low birth weight, developing Sudden Infant Death Syndrome (SIDS) and being born
with other respiratory diseases because nicotine exposure
causes decreased airway size, resulting in a reduction in the
overall growth of the lungs.2
The chemicals found in cigarettes may reduce kidney size
leading to kidney malfunction later in life for the child.2 Newborns were shown to be four times more responsive to
sound stimuli than their nonexposed counterparts resulting
in potential dysfunction in their ability to process auditory
information and potentially leading to both impaired reading
and language skills as they grow up.1 Even though children
exposed to cigarette smoking are initially smaller than those
not exposed to prenatal smoking, they are at a higher risk for
developing obesity later in life which puts them at risk for
comorbid conditions like cardiovascular disease or diabetes.2

Additional Health Risks: Secondhand Smoke and Smoking During Breastfeeding
Following pregnancy, some women choose to breastfeed
their infant. However those who smoke tend to have a smaller milk supply and usually stop breastfeeding their infants
sooner than those who do not smoke.4 It is known that nicotine can easily be transferred into the breast milk in high levels, and the amount of nicotine transferred to the breast milk
is 2.9 times the amount present in the mother's blood plasma
causing the infants to be exposed to nicotine every time they
feed. This exposure to nicotine when feeding can cause
shorter sleep times and altered sleep patterns especially if
mothers smoke just prior to feeding their child.4,S A study by
Primo and colleagues demonstrated that when mothers
smoked before breastfeeding their children only slept for
53.4 minutes whereas children whose mothers did not
smoke before breastfeeding slept on average 84.5 minutes.s
The infants who were exposed to nicotine when they breastfed experienced sleeping disorders. Additionally, the study
showed if the mother smoked during pregnancy and lactation, the child had permanent destruction of the pancreatic 13
cells which caused them to have an impaired glucose tolerance. Based on the findings of these studies, it important that
smoking mothers be counseled on all the harmful chemicals
in tobacco smoke and their potential detrimental effects on
pediatric health. While limited research is currently available
on the impact of e-cigarettes, it is thought that e-cigarettes
have similar risks to regular cigarettes because e-cigarettes
still deliver the same level of nicotine to the mother. Furthermore, the nicotine is passed to the infant in the same way as
from regular cigarettes.
Pharmacists can also educate patients on the additional fetal
health risks of exposure to secondhand smoke and smoking
during breastfeeding. Secondhand smoke is defined as smoke
from a cigarette, pipe or a cigar that is inhaled by people in
close proximity to the person smoking.6 Secondhand smoke
is known to be dangerous and can cause mild symptoms in

children like a stuffy nose, headache, sore throat, eye irritation, tooth decay and hoarseness.7 These children can also
experience more serious health problems like lung cancer,
heart disease, cataracts, wheezing, coughing and ear infections. Studies show children who are exposed to secondhand
smoke are more likely to become sick with diseases like the
common cold, pneumonia or bronchitis and tend to be sick
longer than normal which causes them to miss more school
than children from nonsmoking families. If a child has preexisting asthma, secondhand smoke can trigger asthma attacks which may occur more frequently with an increased
severity. If the asthma attack is severe enough, it could require hospitalization and may be life threatening for the
child.7,s Children who grow up in smoking households are
also more likely to become smokers themselves.7

Smoking During Pregnancy: Patient Perceptions and Demographics
Considering the known fetal and maternal health risks from
smoking and secondhand smoke during pregnancy,
understanding patient perceptions about smoking during
pregnancy is of utmost importance for the pharmacist to initiate interventions for smoking cessation.9 Furthermore, understanding the demographics of pregnant patients who
smoke can help better identify target populations for smoking cessation interventions. According to the American College of Nurse-Midwives, some potential misconceptions for
smoking during pregnancy include:rn
• Smoking hasn't seemed to have any impact on my
health. I got pregnant without any difficulty.
•
1 smoked during my last pregnancy and had a healthy
baby, so this baby will be healthy, too.
• There is nothing wrong with a small baby.
• I am three months pregnant. There is no point in stopping smoking now. The damage is done.
• Smoking relaxes me, and being relaxed is better for my
baby.
• Quitting smoking during pregnancy will be too stressful on my baby.
• Smoking fewer cigarettes during pregnancy is good
enough.
• If I stop smoking, I'll gain too much weight.
• The only way to quit smoking is cold turkey.
• I smoke, so I should not breastfeed my baby.
Approximately 15 to 20 percent of pregnant women smoke
tobacco during pregnancy despite a strong public-health
campaign over the last few decades.2 About 20 percent of
pregnant smokers quit before their initial prenatal visit. Of
women who smoke before pregnancy, 55 percent quit during
their pregnancy, 40 percent of which relapse within six
months after giving birth.1 1 It was reported that the number
of pregnant smokers decreased in half from 1989 to 2000.
The federal government initiative "Healthy People 2020" has
a goal to continue to decrease the number of pregnant smokers to nearly 2 percent,12 The 2011 Pregnancy Risk Assessment and Monitoring System (PRAMS) provided data from
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24 states in regard to various demographics and the percent
of births to smoking mothers. This data can be found in Table
l,12
Quitting smoking within the first three to four months of
pregnancy can yield many benefits including a reduction in
risk of low birth weight, premature birth and stillbirth.13
Considering the extensive need for smoking cessation
interventions in pregnant patients among a variety of demographics, there exists considerable opportunity for pharmacists to initiate smoking cessation with patients particularly in the community setting. Behavioral and psychological
therapy should be offered to smoking patients who are pregnant before a pharmacotherapy option is considered. Nonpharmacologic behavioral strategies are used to help the patient identify the triggers that cause patients to smoke and

how to control impulses.1 4 Pharmacists should offer coping
strategies to help patients overcome barriers to smoking
cessation. The American College of Obstetricians and Gynecologists (ACOG) guidelines suggest strategies to overcoming
common barriers in smoking cessation which pharmacists
can use to initiate smoking cessation interventions (Table 2).15
Approaches to Smoking Cessation: Pharmacologic and
Nonpharmacologic
Among the available interventions pharmacists can recommend in initiating smoking cessation, the 5 A's approach
(Table 3) is a preferred nonpharmacologic intervention.3.15
Given the lack of evidence regarding safety and efficacy of
pharmacologic options for smoking cessation during pregnancy, use of the 5 A's as a first-line measure to assess the
pregnant patient's willingness to quit is recommended. This

Table 1. The 2011 Pregnancy Risk Assessment and Monitoring System (PRAMS) Data for Pregnant Smokers'
Demographics.12
Demographic

Percent of births to smoking mother s

Race
American Indian or Alaska Native mothers

18.0%

Non-Hispanic white mothers

12.4%

African American mothers

7.0%

Asian or Pacific Islander mothers

1.2%

Hispanic mothers

2.0%

Age (years)
<15

2.5%

15-19

10.6%

20-24

13.3%

25+

<10.0%

Mother's Education
Bachelor's degree or more

1.0%

Some college or associate's degree

9.0%

High school diploma

13.8%

9-12 grade education

16.7%

8th grade or less

4.4%

Adapted from: Child Trends Data Bank. Bethesda (MD): Child Trends. Mothers who smoke while pregnant.
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Table 2. Barriers and Coping Strategies for Smoking Cessation.15
Barrier

Coping Strategy

Negative mood

Participate in physical activity, talking to a friend, journaling, taking 10 deep breaths.

Being around
other smokers

Spend more time with nonsmokers, walk away from smokers when you feel like smoking, ask others
around you not to smoke, create a smoke free area in your house.

Triggers

Identify situations that trigger a craving, change your routine after meals such as brushing your teeth
instead of smoking.

Time pressures

Change lifestyle to reduce stress, participate in physical activity.

Adapted from: Phelan S, Albrecht S, Melvin C, Rohweder C, Laping J, Chapin J, Mahoney J. The American College of Obstetricians and Gynecologists. Smoking cessation during pregnancy: a clinician's guide to helping pregnant women quit smoking.

Table 3. The 5 A's Approach to Smoking Cessation: Applied to Pregnant Patients.3· 15

Ask

Ask patient at every health care visit about her tobacco use.
Document answer as a vital sign.
Avoid asking in the form of a yes or no question.
• For example, include a multiple-choice question about tobacco use in the personal patient
information that the patient files upon the first visit, and updates at every subsequent visit.

Advise

Strongly advise every patient to quit using tobacco in a way that is personalized to the patient's
situation.
• Focus on the benefits of quitting for her and the fetus, instead of focusing on negative
outcomes for greatest efficacy. Some patients may know other women who have smoked
during pregnancy and delivered healthy babies.
• Provide educational materials about benefits and risks of tobacco use,
Advise any patients that have quit smoking in the past of the importance to remain abstinent.

Assess

Assess willingness to quit within the next 30 days.
• If the patient is willing, move on to the Assist phase.
• If not, discuss the 5 R's (Table 4) with the patient to motivate them.15 The 5 R's discussion
is directed by the patient and is meant to have the patient generate their own ideas. This
discussion can be spread out over multiple visits if necessary.

Assist

Assist in quitting by offering counseling and treatment options.
• Form a "quit contract" that states "I agree to stop smoking on (date). I understand that
quitting smoking is the best thing I can do to protect my health and the health of my baby."
Include signatures of the patient and the physician.is
• Utilize the STAR approach (Table 5) to plan ahead for challenges in the quitting process.
• Provide self-help materials and ways to get help:
0

1-800-QUIT NOW

www.smokefree.gov
Identify people close to the patient that can help in the quitting process.
0

•

Arrange

Arrange a follow-up date, either to follow up on the phone or in person.
• Provide encouragement and positive reinforcement.
• Encourage the patient to talk about successes and challenges.
• Express empathy and acknowledge that quitting is difficult and setbacks may occur.

Adapted from: Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Rockville (MD): U.S. Department of
Health and Human Services; 2008 May. Phelan S, Albrecht S, Melvin C, Rohweder C, Laping J, Chapin J, Mahoney J. The American College of
Obstetricians and Gynecologists. Smoking cessation during pregnancy: a clinician's guide to helping pregnant women quit smoking.
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approach has had the most success in helping pregnant patients to quit and is considered noninferior to pharmacologic
therapy.is According to ACOG, if a pregnant patient is unwilling to quit after evaluation using the 5 A's strategy, the
patient should be asked to think about quitting between doctor /pharmacy visits. The 5 R's (Table 4) is a motivational
strategy that may help encourage patients who do not want
to quit. The 5 R's can easily be implemented at the close of
conversation. For patients who have decided to quit, the
STAR approach (Table 5) is useful in planning an official quit
date and accounting for challenges the patient may encounter throughout the process.3 Pharmacists should be mindful
of utilizing these approaches in patient encounters.
Nonpharmacologic therapy is the preferred method for
s moking cessation in pregnancy. However, it can be difficult
to implement, and many patients are unsuccessful. Pharmacologic options are available but, generally, pregnant women
are excluded from randomized controlled trials and thus little information exists on the safety and efficacy of the available pharmacologic interventions.3 Evidence is also lacking
that pharmacologic treatment is superior in efficacy to nonpharmacologic treatment.is In pregnant patients that have
been unable to quit using counseling techniques, pharmacists
should counsel on the risks and benefits of drug treatment
for the patient and the fetus. The maternal benefit of quitting
smoking using drug treatment is likely greater than the risk
Table 4. The 5 R's: A Motivational Intervention for
Patients That Do Not Want to Quit. 15

Relevance

Discuss why quitting might be relevant to
the patient personally and to her unborn
child. The goal is to encourage the patient to
quit for personal reasons.

Risk

Ensure the patient understands the negative
health risks of smoking for her and her baby.

Reward

Ensure the patient understands the benefits
to herself and her family if she quits
smoking. Setting a good example is an
important part of parenting and prevention
of smoking habits in the patient's children.

Roadblocks

Reassure the patient that there are strategies for overcoming roadblocks and help is
available any time she decides she is ready
to make the steps to quit smoking.

Repetition

Follow up at every visit and reassess the
patient's willingness to quit. Continue to
repeat the 5 A's and the 5 R's until the
patient is ready to quit.

Adapted from: Phelan S, Albrecht S, Melvin C, Rohweder C, Laping
J, Chapin J, Mahoney J. The American College of Obstetricians and
Gynecologists [Internet]. Smoking cessation during pregnancy: a
clinician's guide to helping pregnant women quit smoking.
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Table 5. ST AR Approach to Planning for Quit Date. 3

Set

Set a definite quit date.

Tell

Tell family and friends about quitting so they
may facilitate the process.

Anticipate

Anticipate challenges and identify barriers
that will or have in the past inhibited the
patient from successfully quitting.

Remove

Remove tobacco products and related items
from the patient's immediate environment,
and have the patient try to avoid items and
places that will trigger thoughts of tobacco
usage.

Adapted from: Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco
use and dependence: 2008 update. Rockville (MD): U.S. Department of Health and Human Services; 2008 May.

to the fetus and, if the mother and physician ultimately decide that pharmacologic treatment is the next best option to
try, close monitoring is required to maximize the safety of
the patient and fetus.13
There are seven FDA-approved pharmacologic treatment
options that are first-line in nonpregnant patients. The options include varenicline (Chantix®), bupropion SR
Zyban®), and a variety of nicotine replacement therapies
(NRT).16 Table 6 outlines the FDA-approved dosing and pregnancy risk levels for each drug.17 Even though the dosages
are FDA -pproved, the data assessing safety and efficacy in
pregnancy is limited with risk categories of C and D for the
options available.18 Pregnancy risk category C implies inadequate studies completed to assess safety, or adverse effects
occurred in animal populations, but human data is unavailable. Category D medications have evidence of fetal risk in
humans and appropriateness of use depends upon the risks
and benefits for the patient.
Conclusion
Women who smoke and are pregnant or planning to become
pregnant may be unaware of the dangers smoking poses to
the fetus and the developing child. Pharmacists, as health
care professionals who are widely available and accessible,
are in an ideal position to positively influence patients, and
particularly pregnant women, to quit smoking. By assessing
willingness to quit smoking and offering extensive counseling, pharmacists can help decrease the number of patients
who smoke and encourage them with successfully achieving
smoking cessation.
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Table 6. Pharmacologic Treatment Options for Smoking Cessation. t 7
Dr ug Name

Varenicline
(Chantix®)

Pregnancy
Risk
Category

Dose

c

• Day 1-3: take 0.5 mg by mouth in the morning.
• Day 4-7: take 0.5 mg by mouth twice daily.
• Weeks 2 - 12: take 1 mg by mouth twice daily.

Bupropion
SR (Zyban®)

c

Nicotine
Replacement
Therapy:

D

Gum

Other Notes

• Day 1-3: take 150 mg tablet by mouth in the
morning.
• Day 4 and beyond: take 150 mg by mouth
twice daily.
• Do not exceed 300 mg per day.

• Begin treatment 1 week before quit date.
Take dose after eating with a large glass of water.
• Typical duration: 12 weeks, but may be continued
another 12 weeks in select patients.

•

• Begin treatment 1- 2 weeks before quit date.
Separate doses by at least 8 hours.
• Do not take before bed in order to minimize
insomnia.
• Typical duration: 7 to 12 weeks, but may be
continued for up to 6 months in select patients.

•

• Ensure the patient is aware that if they continue to
smoke while using NRT, the risk to the fetus is
greater than either alone.13
If first cigarette is used within 30 minutes of

waking, use 4 mg gum.
Iffirst cigarette is used after 30 minutes ofwaking, use 2 mg.
• Week 1-6: chew one piece every 1-2 hours.
• Week 7-9: chew one piece every 2-4 hours.
• Week 10-12: chew one piece every 4-8 hours.

• Maximum: 24 pieces per day.
• Chew gum slowly and "park" on inside of cheek
when the tingling sensation appears.
• When the sensation disappears, chew again.
• Park in different areas of the mouth each time.
• Continue chewing and parking; cycle for about 30
minutes until effect stops.
• Do not eat or drink 15 minutes before or while
using gum.
• Treatment duration: up to 12 weeks.

Lozenge

See gum dosing.

•
•
•
•
•

Patch

If more than 10 cigarettes are used in one day:
• Week 1-6: apply 21 mg patch once daily
• Week 7-8: apply 14 mg patch once daily
• Week 9-10: apply 7 mg patch once daily.
If less than 10 cigarettes are used in one day:
• Week 1-6: apply 14 mg patch once daily
• Week 7-8: apply 7 mg patch once daily.

• Apply the patch to dry, hairless, clean skin.
• Rotate the patch site with each application.
• Patch may be worn up to 16 hours, and it may be
removed at bedtime if the patient has trouble
sleeping or has bothersome vivid dreams.
• Treatment duration: 8-10 weeks.

Nasal Spray
(prescription
only)

Spray once in each nostril once or twice per
hour (0.5 mg per spray).

•
•
•
•

Oral Inhaler
(prescription
only)

Initially use one cartridge every 1-2 hours, or 6
cartridges per day.

• Maximum:16 cartridges per day.
• Continuously puff for 20 minutes for greatest
efficacy.
• Inhale in short breaths toward the back of the
throat, and not the lungs.
• Do not eat or drink 15 minutes prior to or during
inhalation treatment.
• Treatment duration: 3-6 months.

Maximum: 20 lozenges per day.
Do not chew, bite or swallow the lozenge.
Let lozenge dissolve slowly.
Rotate the lozenge around the mouth.
Do not eat or drink 15 minutes before or while
using lozenges.
• Treatment duration: up to 12 weeks.

Maximum: 5 doses per hour or 40 doses per day.
Initial use of8 doses per day is recommended.
Do not sniff, inhale or swallow when spraying.
Treatment duration: 3-6 months.

Adapted from: Pharmacologic product guide: FDA-approved medications for smoking cessation. Regents of the University of California;
1999.
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